Cambridge, June 21st 2023 – Cresset, innovative provider of solutions for CADD, DMTA efficiency and contract research, has expanded its senior leadership team with the appointment of Nick Foster as Vice President of their Discovery CRO business.
In his new role, Nick will be responsible for driving the strategic direction of Cresset’s Discovery CRO business, ensuring organizations have access to the deepest molecular modeling expertise in the industry. In particular, he will focus on expanding our already successful platform of technologies and solutions by continuing to innovate around the application of cutting-edge methods, such as FEP and AI/ML to the critical questions which our team of experts address with customers on a daily basis.
Nick is a highly experienced commercial leader with a 20 year plus career in the pharmaceutical and biotechnology industries. He joins the team at Cresset from Metrion Biosciences, where he served as Chief Commercial Officer and Head of Business Development. He has previously held senior leadership positions with WuXi AppTec and Optibrium.
Commenting on the appointment, Dr Robert Scoffin, Chief Executive Officer at Cresset said, “As part of our ambitious plans to grow and expand the business, Nick will utilize his broad global market knowledge, including experience built in the software and CRO sectors, to ensure we deliver solutions that optimize chemistry R&D innovation and efficiency. We will continue to attract the finest talent into our organization where, as a team, we work collaboratively to deliver best-in-class scientific software and modeling solutions.”
Nick Foster, Vice President Discovery, Cresset added “I am delighted to be joining an organization that has established itself as a leading provider of solutions across the design-make-test-analyze cycle. I look forward to working with the team to support the effective delivery of contract research services, engage with collaborators and further develop global partnerships.”
